Children and Adolescents With Hematologic Cancers Deserve Better End-of-Life Care

Children and adolescents with hematologic malignancies consistently experience higher rates of aggressive care at the end of life. Clinicians and researchers must now turn their attention to reducing this disparity.

Automated summary

Children and adolescents with hematologic malignancies consistently receive higher rates of aggressive care at the end of life, prompting clinicians and researchers to focus on reducing this disparity.